The role of preimplantation genetic diagnosis in diagnosing embryo aneuploidy
Authors:
- Santiago MunnéSMSantiago Munné
- Colin M HowlesCHColin M Howles
- Dagan WellsDWDagan Wells
- 1 October 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 21 (5) , 442-449
Abstract
Use of preimplantation genetic diagnosis to improve in-vitro fertilization outcomes is reviewed. Many embryos produced in vitro contain chromosomal abnormalities and have little potential for forming a viable pregnancy. The most commonly used method for preimplantation genetic diagnosis involves embryo biopsy on day 3 of development, followed by fluorescence in-situ hybridization analysis of 5-12 chromosomes. However, positive results have been more common with single-cell biopsy and the analysis of nine or more chromosomes, including 15, 16, 21, and 22. Comparative genomic hybridization, array-comparative genomic hybridization, and single-nucleotide polymorphism arrays analyze all chromosomes and, although technically demanding and requiring experience for successful use, improve the selection potential of preimplantation genetic diagnosis and minimize error rates. Recent data suggest that biopsy at the blastocyst stage may allow sampling of representative genetic material without compromising embryo viability. The optimal strategy for aneuploidy screening using preimplantation genetic diagnosis seems to be blastocyst biopsy at 5 days and comprehensive chromosome analysis (comparative genomic hybridization, array-comparative genomic hybridization, single-nucleotide polymorphism array). The use of preimplantation genetic diagnosis to assist the identification and preferential transfer of healthy euploid embryos should improve implantation rates, reduce miscarriages and trisomic offspring, and ultimately lead to an increase in live birth rates.Keywords
This publication has 109 references indexed in Scilit:
- Guidelines for good practice in PGD: programme requirements and laboratory quality assuranceReproductive BioMedicine Online, 2008
- Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGHMolecular Human Reproduction, 2008
- High pregnancy rate after comprehensive chromosomal screening of blastocystsFertility and Sterility, 2008
- Recombination mapping: a universal molecular karyotyping method for preimplantation genetic diagnosis of inherited diseaseFertility and Sterility, 2008
- Blastocyst trophectoderm biopsy and preimplantation genetic diagnosis for familial monogenic disorders and chromosomal translocationsPrenatal Diagnosis, 2008
- Preimplantation genetic testing: a Practice Committee opinionFertility and Sterility, 2007
- Increased efficiency of preimplantation genetic diagnosis for infertility using “no result rescue”Fertility and Sterility, 2007
- Discordance among blastomeres renders preimplantation genetic diagnosis for aneuploidy ineffectiveJournal of Assisted Reproduction and Genetics, 2007
- Fluorescence in situ hybridization reanalysis of day-6 human blastocysts diagnosed with aneuploidy on day 3Fertility and Sterility, 2005
- Chromosome Abnormalities in Embryos Obtained After Conventional In Vitro Fertilization and Intracytoplasmic Sperm InjectionFertility and Sterility, 1998